HIGH POWER SHORT DURATION VS LOW POWER LONG DURATION CATHETER ABLATION OF ATRIAL FIBRILLATION

Authors

  • Titus Rheinhardo Lolonlun Borong Regional General Hospital, East Manggarai, Indonesia
  • Daniel Christian Fernandez Harapan Kita Heart and Blood Vessel Hospital, Jakarta Capital Special Region, Indonesia

DOI:

https://doi.org/10.61841/4a4az509

Keywords:

Atrial fibrillation, ablation, high power short duration, low power long duration

Abstract

Backgrounds : Atrial Fibrillation (AF) is a known common arrythmia, affecting around 33 million people worldwide. Catheter ablation is a safe and effective treatment for paroxysmal and persistent AF that are unresponsive to drug treatment. However, long procedural duration of AF ablation has raised the concern of radiation hazard and post-procedural complications. The high power short duration (HPSD) technique is an emerging method that has been introduced as an alternative to reduce procedural time of AF ablation.

Objective: This study attempts to review the safety and efficacy of HSPD compared to the conventional low power long duration (LPLD) ablation in AF patients.

Method : A search through PubMed, Science Direct, JSTORE, and clinicaltrial.gov was conducted. The keywords used were (catheter ablation OR radiofrequency OR pulmonary vein isolation) AND (atrial fibrillation) AND (high power short duration OR 50 W). The search was limited from 2006 to 2024. Risk of bias assessment was conducted through Newcastle-Ottawa Scale (NOS) assessment.

Results: Among 55,802 journals reviewed, we retrieved 10 journals that met the inclusion criteria. This study found that HPSD ablation results in either better or comparable efficacy in maintaining long term sinus rhythm post ablation. Additionally, there was no difference in safety for both HPSD and LPLD. We also recommend using esophageal temperature monitoring probe and adjusting energy delivery during posterior wall ablation to avoid injuring esophagus.

Conclusion: Our study concluded that HPSD ablation is a safe choice of treatment for drug-refractory paroxysmal or persistent AF with a noteworthy outcome compared to LPLD ablation.

References

McCarthy PM, Cox JL, Kislitsina ON, Kruse J, Churyla A, Malaisrie SC, et al. Surgery and Catheter Ablation for Atrial Fibrillation: History, Current Practice, and Future Directions. J Clin Med. 2021 Dec 31;11(1):210.

Parameswaran R, Al-Kaisey AM, Kalman JM. Catheter ablation for atrial fibrillation: current indications and evolving technologies. Nat Rev Cardiol. 2021 Mar 13;18(3):210–25.

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017 Oct;14(10):e275–444.

Kotadia ID, Williams SE, O’Neill M. High-power, Short-duration Radiofrequency Ablation for the Treatment of AF. Arrhythm Electrophysiol Rev. 2020 Feb 11;8(4):265–72.

Gupta A, Perera T, Ganesan A, Sullivan T, Lau DH, Roberts-Thomson KC, et al. Complications of Catheter Ablation of Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1082–8.

Yamagata K, Aldhoon B, Kautzner J. Reduction of Fluoroscopy Time and Radiation Dosage During Catheter Ablation for Atrial Fibrillation. Arrhythm Electrophysiol Rev. 2016;5(2):144.

Bhaskaran A, Chik W, Pouliopoulos J, Nalliah C, Qian P, Barry T, et al. Five seconds of 50–60 W radio frequency atrial ablations were transmural and safe: an in vitro mechanistic assessment and force-controlled in vivo validation. Europace. 2016 May 20;euw077.

Chieng D, Segan L, Sugumar H, Al-Kaisey A, Hawson J, Moore BM, et al. Higher power short duration vs. lower power longer duration posterior wall ablation for atrial fibrillation and oesophageal injury outcomes: a prospective multi-centre randomized controlled study (Hi-Lo HEAT trial). EP Europace. 2023 Feb 16;25(2):417–24.

Downloads

Published

2024-03-04

How to Cite

Rheinhardo Lolonlun, T. ., & Christian Fernandez, D. . (2024). HIGH POWER SHORT DURATION VS LOW POWER LONG DURATION CATHETER ABLATION OF ATRIAL FIBRILLATION. Journal of Advanced Research in Medical and Health Science (ISSN 2208-2425), 10(3), 15-26. https://doi.org/10.61841/4a4az509